Current market data on how medical aesthetic businesses are priced, what drives premium multiples, and what tanks valuations in lower middle market deals.
Med spas in the $1M–$5M revenue range typically trade at 3.5x–6x EBITDA, with premium multiples reserved for businesses with membership revenue, non-owner-dependent provider teams, and clean compliance histories. Key-person risk, deferred revenue liabilities, and state CPOM complexity are the most common valuation discount factors buyers apply during due diligence.
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or High-Risk | $300K–$500K | 3.0x–3.5x | Owner is primary injector, declining revenue, compliance issues, or weak financial documentation. Buyers price in significant transition and regulatory risk. |
| Standard Owner-Operated | $400K–$700K | 3.5x–4.5x | Stable revenue, some membership base, but owner-dependent. Clean books. Moderate provider team in place. SBA 7(a) financing typically used. |
| Growth-Stage with Systems | $600K–$900K | 4.5x–5.5x | 200+ active members, diversified service mix, employed provider team, strong Google reputation, and documented patient retention metrics. |
| Platform-Ready or PE Target | $800K+ | 5.5x–6.5x | Scalable multi-location model, non-owner-operator, high membership density, CPOM-compliant entity structure, and strong revenue growth trajectory. |
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Owner Provider Dependency
Negative — up to 1.5x multiple reductionWhen the owner performs the majority of injections, buyers discount heavily. A fully staffed provider team with independent client relationships commands premium pricing.
Membership Revenue Penetration
Positive — up to 1.0x multiple premiumMed spas with 200+ active recurring members demonstrate predictable monthly cash flow that PE buyers and SBA lenders reward with higher valuations.
CPOM Compliance Structure
Positive or DisqualifyingA properly structured medical director agreement and MSA entity separation removes a key acquisition barrier. Non-compliant structures can kill deals entirely in regulated states.
Equipment Age and CapEx Requirements
Negative — reduces adjusted EBITDAOutdated laser or body contouring devices requiring near-term replacement are treated as deferred capital costs, reducing effective EBITDA and compressing buyer multiples.
Geographic Market and Demographics
Positive — up to 0.5x premiumHigh-income suburban markets with limited competition and strong Google review velocity support premium pricing and faster patient acquisition post-close.
PE-backed aesthetics roll-up platforms have intensified competition for platform-ready med spas with $800K+ EBITDA, pushing top-tier multiples above 6x in competitive processes. SBA lending remains active for sub-$750K EBITDA deals. Buyers are increasingly scrutinizing deferred revenue liabilities from oversold memberships and package balances, which can meaningfully reduce net seller proceeds at closing.
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Med Spa. SBA-eligible business, strong membership revenue penetration, and a seller available for a 12–18 month transition.
Pros for seller
Cons for seller
PE-Backed Roll-Up Platform
Private equity consolidators building a Med Spa portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong membership revenue penetration with minimal owner provider dependency. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
Cons for seller
Strategic Acquirer
Larger Med Spa operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement existing operations. Membership Revenue Penetration is especially valuable when it fills a gap the buyer cannot build organically.
Pros for seller
Cons for seller
Owner-operated injectable-focused med spa, suburban Texas market, 150 active members, owner performing 60% of treatments, clean books
$420K
EBITDA
3.8x
Multiple
$1.6M
Price
Systems-driven med spa, Southeast market, 280 active members, three employed injectors, diversified laser and body contouring services
$680K
EBITDA
5.1x
Multiple
$3.47M
Price
Multi-location aesthetics platform, Midwest, non-owner-operator, 500+ members, CPOM-compliant MSA structure, PE roll-up add-on acquisition
$1.1M
EBITDA
6.0x
Multiple
$6.6M
Price
EBITDA Valuation Estimator
Get your Med Spa business value range instantly
Industry: Med Spa · Multiples based on 3.5x–4.5x (Standard Owner-Operated)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
For Sellers: 4-Step Valuation Walkthrough
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
Address your owner provider dependency before going to market — this is the most common reason Med Spa businesses receive offers at the low end of the 3x–6.5x range. Buyers identify it in diligence and reprice accordingly.
Quantify and document your membership revenue penetration with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.
For Buyers: Validate the Asking Multiple
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Med Spa seller cannot produce reconciled financials, that signals what the full diligence process will look like.
Verify the membership revenue penetration claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Med Spa is worth 6.5x or 3x.
Assess owner provider dependency directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Most lower middle market med spas sell at 3.5x–6x EBITDA. Where you land depends on membership revenue, provider team independence, compliance structure, and documented patient retention metrics.
Yes. SBA 7(a) loans cap around $5M, which anchors pricing for sub-$1M EBITDA deals. Buyers using SBA financing often target 3.5x–4.5x multiples to ensure debt service coverage ratios qualify.
Recurring membership revenue reduces buyer risk and improves cash flow predictability. Med spas with 200+ active members typically earn 0.5x–1.0x higher EBITDA multiples than purely transactional competitors.
CPOM non-compliance can terminate a deal or force costly restructuring post-LOI. Sellers with a properly documented medical director agreement and MSA entity structure attract more buyers and command stronger multiples.
More Med Spa Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required
For Buyers
For Sellers